About Vannsh Life Sciences
Vannsh Life Sciences is a company based in Hyderabad (India) founded in 2009. It operates as a B2B and Manufacturing. The company has 64 employees as of March 31, 2023. Vannsh Life Sciences offers products and services including Bendamustine Hydrochloride, Bortezomib, Capecitabine, Dasatinib, and Erlotinib Hydrochloride. Vannsh Life Sciences operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 64 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vannsh Life Sciences Private Limited
- Date of Incorporation 16 Jul, 2014
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.33 M (USD)45.83as on Mar 31, 2023
-
Net Profit
-$118.01 K (USD)30.69as on Mar 31, 2023
-
EBITDA
$512.15 K (USD)0.75as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
64
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vannsh Life Sciences
Vannsh Life Sciences offers a comprehensive portfolio of products and services, including Bendamustine Hydrochloride, Bortezomib, Capecitabine, Dasatinib, and Erlotinib Hydrochloride.
Anti-cancer API used for treating lymphomas and leukemias.
Proteasome inhibitor for multiple myeloma and mantle cell lymphoma.
Oral chemotherapeutic agent for metastatic breast and colorectal cancers.
Tyrosine kinase inhibitor for chronic myeloid leukemia treatment.
Targeted therapy for non-small cell lung and pancreatic cancers.
Nucleoside analog for treating various solid tumors.
Tyrosine kinase inhibitor for chronic myeloid leukemia.
Antimetabolite used in cancer and autoimmune disease treatments.
Funding Insights of Vannsh Life Sciences
Detailed funding history for Vannsh Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vannsh Life Sciences
Investment portfolio details for Vannsh Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vannsh Life Sciences
Detailed financials for Vannsh Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vannsh Life Sciences Comparisons
Peer comparison for Vannsh Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vannsh Life Sciences
Vannsh Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Vannsh Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vannsh Life Sciences
Complete news archive for Vannsh Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vannsh Life Sciences
Vannsh Life Sciences was founded in 2009.
Vannsh Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Vannsh Life Sciences is 64.
Annual revenue of Vannsh Life Sciences is $5.33M as on Mar 31, 2023.
Vannsh Life Sciences is a specialty pharmaceutical company incorporated in 2014 under Indian Companies Act, focusing on research, development, and manufacturing of high-quality APIs and intermediates. It operates facilities in Hyderabad and Visakhapatnam, India, with capabilities in synthetic chemistry and drug delivery technologies. The company supplies to leading generic firms worldwide, emphasizing quality standards and timely delivery, while maintaining regulatory compliance and innovation in healthcare products.
Vannsh Life Sciences's top competitors include Merck, Roivant Sciences and AbbVie.
Vannsh Life Sciences offers Bendamustine Hydrochloride, Bortezomib, Capecitabine, Dasatinib, and 4 more products and services.